John Wesolowski's most recent trade in Intensity Therapeutics Inc was a trade of 69,745 Common Stock, $0.0001 Par Value done at an average price of $0.3 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intensity Therapeutics Inc | John Wesolowski | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.26 per share. | 30 Jun 2025 | 69,745 | 76,436 | - | 0.3 | 18,203 | Common Stock, $0.0001 Par Value |
| Intensity Therapeutics Inc | John Wesolowski | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | John Wesolowski | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2025 | 100,000 | 100,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | John Wesolowski | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2024 | 70,028 | 70,028 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | John Wesolowski | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 1,000 | 14,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | John Wesolowski | Principal Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 05 Jun 2024 | 1,000 | 6,691 | - | 4 | 4,000 | Common Stock, $0.0001 Par Value |
| Intensity Therapeutics Inc | John Wesolowski | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy Common Stock) | |
| Intensity Therapeutics Inc | John Wesolowski | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy Common Stock) |